A Randomized, Single-center, Open-label, Single-dose Phase 1 Study to Evaluate the Effect of Difference in Ethnicity on the Pharmacokinetics of Imarikiren in the Healthy Adult Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Imarikiren (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Pharmacokinetics
- 09 Feb 2018 New trial record